For research use only. Not for therapeutic Use.
Anethole trithione (CAT: I003951) is a drug primarily used in the treatment of xerostomia, commonly known as dry mouth. It functions by stimulating the salivary glands to increase saliva production, thereby relieving the symptoms associated with dry mouth. Additionally, anethole trithione is currently being investigated for its potential applications in cancer treatment. Studies have suggested that it may exhibit anticancer properties, although further research is needed to fully understand its mechanisms of action and evaluate its efficacy and safety in cancer therapy.
| Catalog Number | I003951 |
| CAS Number | 532-11-6 |
| Molecular Formula | C10H8OS3 |
| Purity | ≥95% |
| Solubility | 43mg/mL in DMSO |
| Storage | Store at -20C |
| Reference | <p style=/line-height:25px/> |
